Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1996 1
1998 2
2000 1
2001 2
2002 1
2003 6
2005 4
2006 4
2007 1
2008 2
2009 1
2010 4
2011 2
2012 2
2013 4
2014 7
2015 4
2016 10
2017 17
2018 14
2019 15
2020 7
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32188649

101 results
Results by year
Filters applied: . Clear all
Page 1
Anticoagulant strategies for the patient with chronic kidney disease.
Law JP, Pickup L, Townend JN, Ferro CJ. Law JP, et al. Clin Med (Lond). 2020 Mar;20(2):151-155. doi: 10.7861/clinmed.2019-0445. Clin Med (Lond). 2020. PMID: 32188649 Free PMC article.
Anticoagulation in chronic kidney disease: from guidelines to clinical practice.
Aursulesei V, Costache II. Aursulesei V, et al. Clin Cardiol. 2019 Aug;42(8):774-782. doi: 10.1002/clc.23196. Epub 2019 May 28. Clin Cardiol. 2019. PMID: 31102275 Free PMC article. Review.
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M, Vandelli P, Mighali P, Vicini R, Coluccio V, D'Amico R; COVID-19 HD Study Group. Marietta M, et al. Trials. 2020 Jun 26;21(1):574. doi: 10.1186/s13063-020-04475-z. Trials. 2020. PMID: 32586394 Free PMC article.
Systemic anticoagulation considerations in chronic kidney disease.
Dager WE, Kiser TH. Dager WE, et al. Adv Chronic Kidney Dis. 2010 Sep;17(5):420-7. doi: 10.1053/j.ackd.2010.06.002. Adv Chronic Kidney Dis. 2010. PMID: 20727512 Review.
Treatment of DVT: how long is enough and how do you predict recurrence.
Agnelli G, Becattini C. Agnelli G, et al. J Thromb Thrombolysis. 2008 Feb;25(1):37-44. doi: 10.1007/s11239-007-0103-z. Epub 2007 Oct 1. J Thromb Thrombolysis. 2008. PMID: 17906973 Review.
Anticoagulation Therapy in Patients with Chronic Kidney Disease.
Saheb Sharif-Askari F, Syed Sulaiman SA, Saheb Sharif-Askari N. Saheb Sharif-Askari F, et al. Adv Exp Med Biol. 2017;906:101-114. doi: 10.1007/5584_2016_109. Adv Exp Med Biol. 2017. PMID: 27628006 Review.
[Anticoagulation and anti platelet therapy in patients with chronic kidney disease].
Schirmer SH, Brandenburg V, Antlanger M. Schirmer SH, et al. Dtsch Med Wochenschr. 2019 Oct;144(20):1423-1427. doi: 10.1055/a-0641-9696. Epub 2019 Oct 8. Dtsch Med Wochenschr. 2019. PMID: 31594017 Review. German.
Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment.
Kooiman J, den Exter PL, Cannegieter SC, le Cessie S, del Toro J, Sahuquillo JC, Pedrajas JM, Huisman MV. Kooiman J, et al. J Thromb Haemost. 2013 Nov;11(11):1968-76. doi: 10.1111/jth.12411. J Thromb Haemost. 2013. PMID: 24112123 Free article.
Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
Huisman MV, Bounameaux H. Huisman MV, et al. Semin Vasc Med. 2005 Aug;5(3):276-84. doi: 10.1055/s-2005-916167. Semin Vasc Med. 2005. PMID: 16123915
Adverse outcomes of anticoagulant use among hospitalized patients with chronic kidney disease: a comparison of the rates of major bleeding events between unfractionated heparin and enoxaparin.
Saheb Sharif-Askari F, Syed Sulaiman SA, Saheb Sharif-Askari N, Al Sayed Hussain A, Railey MJ. Saheb Sharif-Askari F, et al. PLoS One. 2014 Sep 2;9(9):e106517. doi: 10.1371/journal.pone.0106517. eCollection 2014. PLoS One. 2014. PMID: 25181525 Free PMC article.
101 results
Jump to page
Feedback